Patents by Inventor Timothy Isham Shaw

Timothy Isham Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC ANTIGEN RECEPTORS FOR DIRECT AND INDIRECT TARGETING OF FIBRONECTIN-POSITIVE TUMORS
    Publication number: 20220267425
    Abstract: The application relates to a chimeric antigen receptor that directly and/or indirectly targets cells and their uses in tumor immunotherapy. The application also relates to polynucleotides that encode the chimeric antigen receptor and optionally accessory genes, vectors, and host cells comprising the chimeric antigen receptor and optionally a second antigen targeting moiety (e.g., a second chimeric antigen receptor or a bispecific molecule). The application also relates to methods for preparing host cells comprising the chimeric antigen receptor and optionally the second antigen targeting moiety.
    Type: Application
    Filed: July 17, 2020
    Publication date: August 25, 2022
    Applicant: St. Jude Children's Research Hospital, Inc.
    Inventors: Stephen Gottschalk, Jessica Wagner, Timothy Isham Shaw, Jinghui Zhang